359 related articles for article (PubMed ID: 14681681)
21. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
[TBL] [Abstract][Full Text] [Related]
22. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
23. H-ras-1 gene mutations in basal cell carcinoma: automated direct sequencing of clinical specimens.
Wilke WW; Robinson RA; Kennard CD
Mod Pathol; 1993 Jan; 6(1):15-9. PubMed ID: 8426854
[TBL] [Abstract][Full Text] [Related]
24. Point mutations in both transforming and non-transforming codons of the N-ras proto-oncogene of Ph+ leukemias.
Rovera G; Reichard BA; Hudson S; Bittenbender S; Yamada M; Tournay O; Preisler HD
Oncogene; 1989 Jul; 4(7):867-72. PubMed ID: 2666907
[TBL] [Abstract][Full Text] [Related]
25. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
[TBL] [Abstract][Full Text] [Related]
26. Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.
Iwaya T; Maesawa C; Kimura T; Ogasawara S; Ikeda K; Kimura Y; Noda Y; Ishida K; Sato N; Saito K; Masuda T
Oncol Rep; 2005 Apr; 13(4):703-7. PubMed ID: 15756445
[TBL] [Abstract][Full Text] [Related]
27. Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
Murua Escobar H; Günther K; Richter A; Soller JT; Winkler S; Nolte I; Bullerdiek J
Anticancer Res; 2004; 24(5A):3027-8. PubMed ID: 15517911
[TBL] [Abstract][Full Text] [Related]
28. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
29. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
[TBL] [Abstract][Full Text] [Related]
30. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
31. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
[TBL] [Abstract][Full Text] [Related]
32. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
33. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus.
Lee JY; Dong SM; Shin MS; Kim SY; Lee SH; Kang SJ; Lee JD; Kim CS; Kim SH; Yoo NJ
Biochem Biophys Res Commun; 1997 Aug; 237(3):667-72. PubMed ID: 9299424
[TBL] [Abstract][Full Text] [Related]
34. ras gene mutations in human prostate cancer.
Carter BS; Epstein JI; Isaacs WB
Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
[TBL] [Abstract][Full Text] [Related]
35. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of allelic losses in primary melanoma.
Healy E; Belgaid C; Takata M; Harrison D; Zhu NW; Burd DA; Rigby HS; Matthews JN; Rees JL
Oncogene; 1998 Apr; 16(17):2213-8. PubMed ID: 9619830
[TBL] [Abstract][Full Text] [Related]
37. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
38. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
[TBL] [Abstract][Full Text] [Related]
39. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
40. Absence of BRAF and NRAS mutations in uveal melanoma.
Cruz F; Rubin BP; Wilson D; Town A; Schroeder A; Haley A; Bainbridge T; Heinrich MC; Corless CL
Cancer Res; 2003 Sep; 63(18):5761-6. PubMed ID: 14522897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
